Carnitine/Organic Cation Transporter OCTN2 (Slc22a5) Is Responsible for Renal Secretion of Cephaloridine in Mice

Drug Metabolism and Disposition

Volumn 37, Issue 5, 2009, Pages 1009-1016

  Kano, Takashi ^a   Kato, Yukio ^a   Ito, Kimihiro ^a   Ogihara, Takuo ^b   Kubo, Yoshiyuki ^a   Tsuji, Akira ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; CEFALORIDINE; ORGANIC CATION TRANSPORTER 2; PROTEIN SLC22A5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG ELIMINATION; DRUG UPTAKE; FEMALE; GLOMERULUS FILTRATION; KIDNEY TUBULE EXCRETION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFECTIVE AGENTS; BLOOD PROTEINS; CARNITINE; CEPHALORIDINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLOMERULAR FILTRATION RATE; KIDNEY; MALE; MEMBRANES; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; OOCYTES; ORGANIC CATION TRANSPORT PROTEINS; PROTEIN BINDING; RNA, COMPLEMENTARY; TRANSFECTION; XENOPUS LAEVIS;

MUS; XENOPUS LAEVIS;

EID: 66449112180     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.025015     Document Type: Article

References (37)

1. Amat di San Filippo C and Longo N (2004) Tyrosine residues affecting sodium stimulation of carnitine transport in the OCTN2 carnitine/organic cation transporter. J Biol Chem 279:7247-7253.
2. Atkinson RM, Caisey JD, Currie JP, Middleton TR, Pratt DA, Sharpe HM, and Tomich EG (1966) Subacute toxicity of cephaloridine to various species. Toxicol Appl Pharmacol 8:407-428.
3. Barza M (1978) The nephrotoxicity of cephalosporins: an overview. J Infect Dis 137 (Suppl):S60-S73.
4. Bergwerk AJ, Shi X, Ford AC, Kanai N, Jacquemin E, Burk RD, Bai S, Novikoff PM, Stieger B, MeierPJ, et al. (1996) Immunologic distribution of an organic anion transport protein in rat liver and kidney. Am J Physiol 271:G231-G238.
5. Breningstall GN (1990) Carnitine deficiency syndromes. Pediatr Neurol 6:75-81.
6. Cheng X, Maher J, Lu H, and Klaassen CD (2006) Endocrine rgulation of gender-divergent mouse organic anion-transporting polypeptide (Oatp) expression. Mol Pharmacol 70:1291-1297.
7. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, et al. (2002) Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature 417:447-452.
8. Ganapathy ME, Huang W, Rajan DP, Carter AL, Sugawara M, Iseki K, Leibach FH, and Ganapathy V (2000) /3-Lactam antibiotics as substrates for OCTN2, an organic cation/ carnitine transporter. J Biol Chem 275:1699-1707.
9. Gotoh Y, Kato Y, Stieger B, Meier PJ, and Sugiyama Y (2002) Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17/3-D-glucuronide in rats. Am J Physiol Endocrinol Metab 282:E1245-E1254.
10. Grigat S, Fork C, Bach M, Golz S, Geerts A, Schomig E, and Grundemann D (2009) The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate. Drug Metab Dispos 37:330-337.
11. Grube M, Schwabedissen HM, Draber K, Prager D, Moritz KU, Linnemann K, Fusch C, Jedlitschky G, and Kroemer HK (2005) Expression, localization, and function of the carnitine transporter OCTN2 (SLC22A5) in human placenta. Drug Metab Dispos 33:31-37.
12. Inano A, Sai Y, Nikaido H, Hasimoto N, Asano M, Tsuji A, and Tamai I (2003) Acetyl-L- carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2. Biopharm Drug Dispos 24:357-365.
13. Ito K, Kato Y, Tsuji H, Nguyen HT, Kubo Y, and Tsuji A (2007) Involvement of organic anion transport system in transdermal absorption of flurbiprofen. J Control Release 124:60-68.
14. Iwata D, Kato Y, Wakayama T, Sai Y, Kubo Y, Iseki S, and Tsuji A (2008) Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carni- tine to the heart. Drug Metab Pharmacokinet 23:207-215.
15. Jung KY, Takeda M, Shimoda M, Narikawa S, Tojo A, Kim DK, Chairoungdua A, Choi BK, Kusuhara H, Sugiyama Y, et al. (2002) Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1. Life Sci 70:1861-1874.
16. Kato Y, Kuge K, Kusuhara H, Meier PJ, and Sugiyama Y (2002) Gender difference in the urinary excretion of organic anions in rats. J Pharmacol Exp Ther 302:483-489.
17. Kato Y, Sugiura M, Sugiura T, Wakayama T, Kubo Y, Kobayashi D, Sai Y, Tamai I, Iseki S, and Tsuji A (2006) Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Mol Pharmacol 70:829-837.
18. Kido Y, Tamai I, Ohnari A, Sai Y, Kagami T, Nezu J, Nikaido H, Hashimoto N, Asano M, and Tsuji A (2001) Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J Neurochem 79:959-969.
19. Koizumi A, Nozaki J, Ohura T, Kayo T, Wada Y, Nezu J, Ohashi R, Tamai I, Shoji Y, Takada G, et al. (1999) Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet 8:2247-2254.
20. Koizumi T, Nikaido H, Hayakawa J, Nonomura A, and Yoneda T (1988) Infantile disease with microvesicular fatty infiltration of viscera spontaneously occurring in the C3H-H-2° strain of mouse with similarities to Reye's syndrome. Lab Anim 22:83-87.
21. Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa O, and Inui K (2002) Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 13:866-874.
22. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, et al. (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91-94.
23. Ohashi R, Tamai I, Nezu Ji J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, and Tsuji A (2001) Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol 59:358-366.
24. +-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 291:778 -784.
25. +/multidrug antiporter in Vibrio parahaemolyticus. J Bacteriol 187:1552-1558.
26. Shekhawat PS, Yang HS, Bennett MJ, Carter AL, Matern D, Tamai I, and Ganapathy V (2004) Carnitine content and expression of mitochondrial beta-oxidation enzymes in placentas of wild-type (OCTN2(+/+)) and OCTN2 null (OCTN2(-/-)) mice. Pediatr Res 56:323-328.
27. Takeda M, Tojo A, Sekine T, Hosoyamada M, Kanai Y, and Endou H (1999) Role of organic anion transporter 1 (OAT1) in cephaloridine (CER)-induced nephrotoxicity. Kidney Int 56:2128 -2136.
28. Tamai I, China K, Sai Y, Kobayashi D, Nezu J, Kawahara E, and Tsuji A (2001) Na+-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochim Biophys Acta 1512:273-284.
29. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, and Tsuji A (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carni- tine transporter OCTN2. J Biol Chem 273:20378-20382.
30. Tamai I, Ohashi R, Nezu JI, Sai Y, Kobayashi D, Oku A, Shimane M, and Tsuji A (2000) Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275:40064-40072.
31. Treem WR, Stanley CA, Finegold DN, Hale DE, and Coates PM (1988) Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts. N Engl J Med 319:1331-1336.
32. Uchino H, Tamai I, Yabuuchi H, China K, Miyamoto K, Takeda E, and Tsuji A (2000) Faropenem transport across the renal epithelial luminal membrane via inorganic phosphate transporter Nptl. Antimicrob Agents Chemother 44:574-577.
33. Ueo H, Motohashi H, Katsura T, and Inui K (2005) Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOATl. Biochem Pharmacol 70:1104-1113.
34. Urban TJ, Gallagher RC, Brown C, Castro RA, Lagpacan LL, Brett CM, Taylor TR, Carlson EJ, Ferrin TE, Burchard EG, et al. (2006) Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5). Mol Pharmacol 70:1602-1611.
35. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, and Ganapathy V (1999) Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 290:1482-1492.
36. Yamaoka K, Nakagawa T, and Uno T (1978) Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm 6:547-558.
37. Yokogawa K, Higashi Y, Tamai I, Nomura M, Hashimoto N, Nikaido H, Hayakawa J, Miyamoto K, andTsujiA(1999) Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice. J Pharmacol Exp Ther 289:224-230.